Exact Mass: 557.1517868000001
Exact Mass Matches: 557.1517868000001
Found 97 metabolites which its exact mass value is equals to given mass value 557.1517868000001,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Vantin
C21H27N5O9S2 (557.1250132000001)
The 1-[(isopropoxycarbonyl)oxy]ethyl (proxetil) ester prodrug of cefpodoxime. After swallowing, hydrolysis of the ester group occurs in the intestinal epithelium, to release active cefpodoxime in the bloodstream. It is used to treat acute otitis media, pharyngitis, and sinusitis. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Azidopine
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels
Rhodomycin D
An anthracycline that is aklavinone having a 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl residue attached at position 4 via a glycosidic linkage.
dTDP-3-N,N-dimethylamino-4-oxo-2,3,6-trideoxy-D-glucose
dTDP-3-N,N-dimethylamino-4-keto-2,3,6-trideoxy-L-allose
cefpodoxime proxetil
C21H27N5O9S2 (557.1250132000001)
Guadecitabine
Cys Cys Phe Trp
Cys Cys Trp Phe
Cys Phe Cys Trp
Cys Phe Trp Cys
Cys Ser Trp Tyr
Cys Ser Tyr Trp
Cys Trp Cys Phe
Cys Trp Phe Cys
Cys Trp Ser Tyr
Cys Trp Tyr Ser
Cys Tyr Ser Trp
Cys Tyr Trp Ser
Phe Cys Cys Trp
Phe Cys Trp Cys
Phe Trp Cys Cys
Met Met Asn Tyr
C23H35N5O7S2 (557.1977800000001)
Met Met Tyr Asn
C23H35N5O7S2 (557.1977800000001)
Met Asn Met Tyr
C23H35N5O7S2 (557.1977800000001)
Met Asn Tyr Met
C23H35N5O7S2 (557.1977800000001)
Met Tyr Met Asn
C23H35N5O7S2 (557.1977800000001)
Met Tyr Asn Met
C23H35N5O7S2 (557.1977800000001)
Asn Met Met Tyr
C23H35N5O7S2 (557.1977800000001)
Asn Met Tyr Met
C23H35N5O7S2 (557.1977800000001)
Asn Tyr Met Met
C23H35N5O7S2 (557.1977800000001)
Ser Cys Trp Tyr
Ser Cys Tyr Trp
Ser Trp Cys Tyr
Ser Trp Tyr Cys
Ser Tyr Cys Trp
Ser Tyr Trp Cys
Trp Cys Cys Phe
Trp Cys Phe Cys
Trp Cys Ser Tyr
Trp Cys Tyr Ser
Trp Phe Cys Cys
Trp Ser Cys Tyr
Trp Ser Tyr Cys
Trp Tyr Cys Ser
Trp Tyr Ser Cys
Tyr Cys Ser Trp
Tyr Cys Trp Ser
Tyr Met Met Asn
C23H35N5O7S2 (557.1977800000001)
Tyr Met Asn Met
C23H35N5O7S2 (557.1977800000001)
Tyr Asn Met Met
C23H35N5O7S2 (557.1977800000001)
Tyr Ser Cys Trp
Tyr Ser Trp Cys
Tyr Trp Cys Ser
Tyr Trp Ser Cys
SGI-110
C471 - Enzyme Inhibitor > C2083 - DNA Methyltransferase Inhibitor C274 - Antineoplastic Agent > C132686 - Demethylating Agent D000970 - Antineoplastic Agents
Canertinib dihydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents D000970 - Antineoplastic Agents D002317 - Cardiovascular Agents
1-[(Isopropoxycarbonyl)oxy]ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylate
C21H27N5O9S2 (557.1250132000001)
[1,1-Biphenyl]-4-carboxaldehyde,4-[bis(4-formyl[1,1-biphenyl]-4-yl)amino]-
Pixantrone maleate
C25H27N5O10 (557.1757842000001)
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors
(2R,4S)-4-[(2R,4S,5S,6S)-4-azaniumyl-5-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate
(2R,4S)-4-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-2-ethyl-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylic acid
(E)-CefpodoximeProxetil
C21H27N5O9S2 (557.1250132000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
[(2S,3R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methyl [5-(4-amino-2-oxo-1,3,5-triazin-1-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate
(2-amino-2-oxoethyl)-[(E)-3-[7-[[(2E)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(fluoromethoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]prop-2-enyl]-ethyl-methylazanium
cefpodoxime proxetil
C21H27N5O9S2 (557.1250132000001)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
4-[6-(diethylamino)-3-(diethyliminio)-3H-xanthen-9-yl]benzene-1,3-disulfonate
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines D004396 - Coloring Agents > D005456 - Fluorescent Dyes
(1R,2R,4S)-4-[(3-azaniumyl-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-2-ethyl-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
(2-amino-2-oxoethyl)-[(E)-3-[(6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(fluoromethoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]prop-2-enyl]-ethyl-methylazanium
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
2-fluoro-N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzenesulfonamide
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2R,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2S,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
N-[(2R,3R)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C25H33Cl2N3O5S (557.1517868000001)
FMN-L-threonine
A L-threonine derivative that is L-threonine attached via its side-chain to FMN via a phosphate linkage.
10-Carboxy-13-deoxydaunorubicin
An anthracycline antibiotic that is 13-deoxydaunorubicin substituted at position 10 by a carboxy group.
(1R,2S,3S,4R)-6-[1-[(4-chloro-3-sulfamoylbenzoyl)amino]-5-hydroxy-2-methyl-2,3,4,5-tetrahydroindol-4-yl]-2,3,4-trihydroxycyclohexane-1-carboxylic acid
C23H28ClN3O9S (557.1234708000001)
Azidopine
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D000345 - Affinity Labels
10-carboxy-13-deoxydaunorubicin zwitterion
A zwitterion obtained by transfer of a proton from the carboxy to the primary amino group of 10-carboxy-13-deoxydaunorubicin; major species at pH 7.3.
2,3,20,23,27-pentahydroxy-6-methoxy-4-methyl-18,25-dioxo-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),5,8,10,12,17(26),19,21,23,27-decaene-5-carboxylic acid
methyl (2r)-4-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
2-amino-3-(3,4,5-trihydroxyphenyl)-n-[2-(3,4,5-trihydroxyphenyl)-1-{[(1z)-2-(3,4,5-trihydroxyphenyl)ethenyl]-c-hydroxycarbonimidoyl}ethyl]propanimidic acid
(2r,3s,4s,7s,14s)-2,3,20,23,27-pentahydroxy-6-methoxy-4-methyl-18,25-dioxo-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),5,8,10,12,17(26),19,21,23,27-decaene-5-carboxylic acid
(2z)-2-(2-imino-3h-1,3-thiazol-4-yl)-n-[(6r,7r)-2-({1-[(isopropoxycarbonyl)oxy]ethoxy}carbonyl)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]-2-(methoxyimino)ethanimidic acid
C21H27N5O9S2 (557.1250132000001)